MedPath
NMPA Approval

Zanidatamab for Injection

国药准字S20250030

May 27, 2025

Drug Information

注射用泽尼达妥单抗

百赫安

注射剂

300mg/瓶

生物制品

May 27, 2025

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区桑田街218号生物产业园9栋

Manufacturing Company

江苏省无锡市滨湖区马山梅梁路108号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用泽尼达妥单抗 - NMPA 批准文号 | MedPath